English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

A fluorescent derivatization reagent, 3,6-dimethoxy-9-phenyl-9H-carbazole-1-sulfonyl chloride (DPCS-Cl), previously designed, synthesized and developed for amino acids labeling, is here employed. It was used as a pre-column derivatization reagent for the determination of proline (Pro) and hydroxyproline (Hyp) with high-performance liquid chromatography. Both of the analytes were labeled with DPCS-Cl at 60°C for 30 min. The optimized concentration of DPCS-Cl was 25 µg mL -1 and the molar ratio of analytes to DPCS-Cl was 1:6. Excitation wavelength of 318 nm and emission wavelength of 440 nm were selected for the fluorescence detection. For Pro and Hyp, the linear correlation coefficients were all &gt;0.999; the linear ranges of calibration curve were all 5.0 nmol L -1 to 5.0 μmol L -1 ; the detection limits were 20.0 and 10.0 fmol, respectively; the intra-day and inter-day relative standard deviations were 2.6-3.3% and 3.5-4.6%, respectively. This reagent was applied to the determination of Pro and Hyp in plasma of myeloma patients with its merits of high efficiency of derivatization, stability of the derivatives and high sensitivity.

Development of a Fluorescent Labeling Reagent for Determination of Proline and Hydroxyproline in Myeloma Patient Plasma by HPLC-FLD